Choosing the Best Wegovy Provider in the UK: What Actually Matters

The biggest myth: a lower price means you have found a better deal

Most people searching for the best Wegovy provider start from the assumption that price is the primary variable. It is understandable, private weight-loss treatment is not cheap, and comparison shopping is a normal instinct. The myth worth correcting first is that a cheaper listing reflects a comparable service at a better margin. For a prescription medicine, it usually reflects something missing: a skimped clinical review, a grey-market supply chain, or both.

Wegovy's UK list price has changed substantially. When Eli Lilly raised Mounjaro prices in September 2025, Novo Nordisk's pricing also shifted across the market; reputable private providers typically charge somewhere in the range of £149–£375 per month depending on dose and what is bundled in. If a price sits well below that range, it is worth asking what the shortcut is. Providers who keep costs low often do so by automating the clinical stage (using questionnaires processed by software rather than reviewed by a named prescriber) or by sourcing medicine outside the licensed UK supply chain.

For a prescription-only medicine, the cheapest option answers the wrong question. The right question is: who reviewed my case, and where did this pen come from? If you want a fuller breakdown of what private treatment costs and why the components matter, our cost guide covers that ground without softening the answer.

What a legitimate Wegovy provider actually looks like in practice

NICE's guidance on semaglutide for weight management (TA875) was written for NHS pathways, but the standards it describes (proper clinical assessment, ongoing monitoring, support alongside treatment) reflect what good private care should also include. NICE's appraisal of semaglutide (TA875) is worth reading if you want to understand what clinical oversight of this medicine is supposed to involve.

In practice, the markers of a legitimate provider are specific. The pharmacy should be on the GPhC register, that is verifiable in seconds. The prescriber issuing your prescription should be a named, registered Independent Prescriber, not a generic clinical team. Identity verification and live weight checks should be part of the process, not optional extras bolted on for appearances. A provider that sends you medicine without those steps has not met the standard; it has bypassed it.

At nume, weight is verified on video before treatment starts. Transfer patients provide evidence of their current dose before it is continued. Every repeat order is clinically re-reviewed, there are no automatic renewals. Those are not selling points invented for a webpage; they are the baseline for dispensing a medicine that requires ongoing clinical judgment. You can read more about how Wegovy providers differ on what they include and how they handle safety checks.

Red flags that should make you pause when comparing providers

The MHRA has been direct about the risks of counterfeit weight-loss pens. Fake semaglutide pens have been seized in significant quantities across the UK, some containing insulin rather than semaglutide, a potentially dangerous substitution. The first illicit manufacturing site producing counterfeit tirzepatide pens was raided in 2025. These are not edge cases; they represent a genuine supply-chain risk that a regulated pharmacy actively protects you against.

Specific things worth questioning before committing to any Wegovy provider: Can you find the pharmacy on the GPhC register? Is there a named prescriber (not just a clinical team) whose registration you can verify? Is a prescription issued before payment is taken? Does the consultation involve real questions about your medical history, current medicines and relevant conditions, or does it feel like a checkbox exercise designed to approve rather than to assess?

Discount codes for prescription medicines from unverified sellers are a consistent red flag. Offers framed around urgency or scarcity are another. If something about the process feels designed to speed past the clinical stage rather than through it, that instinct is worth trusting. You can report suspect sellers through the MHRA's Yellow Card scheme if you encounter them.

How to use this information when you are ready to take a step forward

Knowing what to look for is most of the work. The rest is checking: look up any provider on the GPhC register, read what the clinical review actually involves, and satisfy yourself that the supply chain is the licensed one. If you are considering switching from your current Wegovy provider, the process at a well-run pharmacy is straightforward, transfer patients are reviewed on the basis of their treatment history, and a clinical conversation about your progress is part of that.

Eligibility for Wegovy follows the licensed criteria: a BMI of 30 or above, or 27 or above alongside a qualifying weight-related condition such as type 2 diabetes, hypertension or high cholesterol. The NHS also recommends lower BMI thresholds for some ethnic backgrounds under its published guidance. BMI alone does not determine suitability; a prescriber considers the full picture, including any medicines you take and any conditions that might affect how treatment goes. If you want to understand where the best place to buy Wegovy in the UK really is and what separates a trustworthy option from a convenient one, the clinical infrastructure behind any provider matters more than the headline price.

When you are ready, the starting point is a free consultation. Your answers are reviewed the same day by a GPhC-registered prescriber. If treatment is clinically appropriate, your prescription is issued and your order dispatched the same day for free next-working-day DPD delivery, tracked, in a plain unbranded box, with the pen packed and ready to go. Check your eligibility and start your consultation here.